Inoviq Ltd. Health Care
Cancer Healthcare Medical North America

$0.850 0.030 (3.66%)

High $0.99	Low $0.84	Trades 317	Turnover $865,876	Volume 942,590
30 June 2023 at 4:10pm

Market Cap (23-Jul) $27,451,212 (0th)	Close (30-Jun) $0.85 0 (0%)	Volume (30-Jun) 942,590	Shortsold (20-Jul) 27 (0.00%) (685th)
52w High $0.57	52w Low $0.190	P/E -	EPS -0.06

Short Interest

ASIC data, 20 Jul 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

685th

of 709 shorted ASX stocks

Peak Short

0.58%

Oct 2025

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	IIQ IIQ Ann: Notification of cessation of securities - IIQ
	1 (current) 2 3
	IIQ IIQ Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation
	IIQ IIQ Ann: INOVIQ Investor Briefing
	IIQ IIQ Ann: Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test
	IIQ IIQ Ann: ISEV Meeting Presentations
	IIQ IIQ Ann: Appendix 4C and Quarterly Activities Report - March 2023
	IIQ IIQ Ann: INOVIQ to present new EXO-NET data at ISEV Annual Meeting
	IIQ IIQ Ann: Change of Director's Interest Notice - Philip Powell
	IIQ IIQ Ann: Change of Director's Interest Notice - Philip Powell
	IIQ IIQ Ann: Appendix 4D and Half Year Financial Report
	IIQ IIQ Ann: Positive results for SubB2M Breast Cancer Test
	IIQ IIQ Ann: Notification regarding unquoted securities - IIQ
	IIQ IIQ Ann: Notification of cessation of securities - IIQ
	IIQ IIQ Ann: Appendix 4C & Quarterly Activities Report - December 2022
	IIQ IIQ Ann: Final Director's Interest Notice
	IIQ IIQ Ann: Resignation of Director
	IIQ IIQ Ann: Positive EXO-NET Results in Ovarian Cancer
	IIQ IIQ Ann: MST Access Diagnostics Forum Presentation
	IIQ IIQ Ann: Change in substantial holding
	IIQ IIQ Ann: Results of 2022 Annual General Meeting
	IIQ IIQ Ann: CEO AGM Presentation
	IIQ IIQ Ann: INOVIQ Settles Legal Proceedings
	IIQ IIQ Ann: Commercial and R&D Update
	IIQ IIQ Ann: Healthcare Conference Investor Presentation
	IIQ IIQ Ann: Appendix 4C - Statement pursuant to Listing Rule 4.7C.3
	IIQ IIQ Ann: IIQ Appendix 4C & Quarterly Activities Report-September 2022
	IIQ IIQ Ann: Canadian Patent Granted for BARD1 Technology
	IIQ IIQ Ann: Investor Presentation
	IIQ IIQ Ann: Notice of Annual General Meeting
	IIQ IIQ Ann: Receipt of R&D Tax Incentive Refund
	IIQ IIQ Ann: INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform
	IIQ IIQ Ann: Appendix 4G and Corporate Governance Statement
	IIQ IIQ Ann: Appointment/Resignation of CFO and Company Secretary
	IIQ IIQ Ann: Notification of cessation of securities - IIQ
	IIQ IIQ Ann: Notice required under listing rule 3.13.1
	IIQ IIQ Ann: 2022 Annual Report and update on results
	IIQ IIQ Ann: Appendix 4E and Preliminary Financial Report
	IIQ IIQ Ann: IIQ Investor Presentation
	IIQ IIQ Ann: INOVIQ Investor Briefing Invitation - June 2022 Quarter
	IIQ IIQ Ann: IIQ Appendix 4C & Quarterly Activities Report - June 2022
	IIQ IIQ Ann: Positive SubB2M IHC Results for Melanoma
	IIQ IIQ Ann: hTERT US Patent Granted
	IIQ IIQ Ann: INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out
	IIQ IIQ Ann: SubB2M US Patent Grant and Program Update
	IIQ IIQ Ann: INOVIQ&University of Sydney Present New EXO-NET Data at ISEV
	IIQ IIQ Ann: Change of Director's Interest - Philip Powell
	IIQ IIQ Ann: IIQ Investor Presentation
	IIQ IIQ Ann: Change of Director's Interest - Dr Geoffrey Cumming
	IIQ IIQ Ann: Change of Director's Interest - Philip Powell
	IIQ IIQ Ann: INOVIQ Investor Briefing Invitation

End of Day Prices

Date	Close	Volume	Change
23-Jul	$0.22	98,381	+0.02 (10.26%)
22-Jul	$0.20	130,676	-0.01 (2.50%)
21-Jul	$0.20	70,007	0.00 (0.00%)
20-Jul	$0.20	79,380	-0.01 (4.76%)
17-Jul	$0.21	95,123	-0.19 (47.50%)
18-Sep	$0.40	53,103	+0.01 (2.56%)
12-Sep	$0.39	23,874	0.00 (0.00%)
11-Sep	$0.39	58,846	-0.01 (2.50%)
05-Sep	$0.40	41,812	+0.01 (2.56%)
04-Sep	$0.39	60,992	-0.01 (2.50%)
03-Sep	$0.40	3,459	-0.01 (2.44%)
29-Aug	$0.41	8,939	0.00 (0.00%)
28-Aug	$0.41	5,037	+0.01 (2.50%)
22-Aug	$0.40	62,899	0.00 (0.00%)
21-Aug	$0.40	40,614	-0.03 (6.98%)
4 up, 7 down, and 4 flat days

Inoviq Ltd. Health Care
Cancer Healthcare Medical North America

Short Interest

Followers

Prices

Announcements

End of Day Prices

IIQ Inoviq Ltd. Health Care Cancer Healthcare Medical North America

Short Interest

Followers

Prices

Announcements

End of Day Prices

Inoviq Ltd. Health Care
Cancer Healthcare Medical North America